Redesign Science is a computational chemistry company setting a new standard for early-stage, small molecule drug discovery.
Redesign Science has raised $15.0M in total funding. The most recent round was Seed. The last funding was announced in December 2021.
Redesign Science's investors include 5Y Capital, Acequia Capital (AceCap), Preface Ventures, Creative Destruction Lab, ZhenFund.
Redesign Science is headquartered in New York, United States.
Redesign Science is a computational chemistry company setting a new standard for early-stage, small molecule drug discovery.
Redesign Science is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Redesign Science — Funding & Investors." VCBacked, December 8, 2021, https://www.vcbacked.co/company/redesign-science. Accessed July 21, 2026.
VCBacked. (2021). Redesign Science — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/redesign-science
{{cite web |title=Redesign Science — Funding & Investors |url=https://www.vcbacked.co/company/redesign-science |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated